Provided by Tiger Trade Technology Pte. Ltd.

HBM HOLDINGS-B

16.540
+0.5303.31%
Volume:7.87M
Turnover:130.41M
Market Cap:14.37B
PE:19.18
High:16.950
Open:15.890
Low:15.810
Close:16.010
52wk High:17.980
52wk Low:9.460
Shares:869.00M
HK Float Shares:869.00M
Volume Ratio:1.00
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.862
ROE:37.55%
ROA:14.08%
PB:4.99
PE(LYR):19.18
PS:11.61

Loading ...

HBM Holdings and Baidu's Biotech Arm Forge AI Drug Discovery Alliance, Launching MegaStream TechBio

Stock News
·
Jun 15

HBM Holdings partners with BioMap to co-found AI drug R&D venture MegaStream TechBio

Reuters
·
Jun 15

Hbm - Co and Biomap to Jointly Initiate Megastream Techbio

THOMSON REUTERS
·
Jun 15

Hbm - Co and Biomap Enter Global Strategic Partnership for AI-Driven Biologics

THOMSON REUTERS
·
Jun 15

HBM Holdings-B Prevails in Patent Infringement Case Against Amgen, Awarded Approximately $20.2 Million with Potential for Triple Damages

Stock News
·
Jun 15

Harbour Biomed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape

THOMSON REUTERS
·
Jun 15

HBM Holdings wins US patent jury verdict against Amgen, awarded USD 20.2 million damages

Reuters
·
Jun 15

Hbm - Jury Returns Verdict in Favor of Harbour Antibodies Against Amgen in U.S. Patent Case

THOMSON REUTERS
·
Jun 15

Hbm Holdings - Jury Verdict in U.S. Patent Infringement Litigation

THOMSON REUTERS
·
Jun 15

Hbm Holdings - IF Such Enhanced Damages Are Granted in Full, Award Could Increase to up to Approximately US$60.6 Mln

THOMSON REUTERS
·
Jun 15

Hbm Holdings - Harbour Antibodies Is Entitled to Damages of US$20.2 Mln Being Full Amount Requested at Trial

THOMSON REUTERS
·
Jun 15

HBM Holdings (SEHK:2142) Stock Valuation After New IND Milestone For Cancer Antibody HBM7004

Simply Wall St.
·
Jun 13

Amgen owes $20.2 million in antibody patent lawsuit, US jury says

Reuters
·
Jun 13

Harbour BioMed appoints Sana Biotechnology CSO Dhavalkumar Patel as scientific advisor

Reuters
·
Jun 12

Press Release: Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor

Dow Jones
·
Jun 12

Harbour BioMed appoints Luisa Salter-Cid as scientific advisor

Reuters
·
Jun 11

BUZZ-China's HBM climbs on regulator's nod on application of new cancer drug

Reuters
·
Jun 10

Hong Kong Stocks Show Movement: Super-Long-Acting Anti-TSLP Antibody Phase II Trial Completes First Dosing; HBM Holdings-B and SKB BIO Both Surge Over 5% During Session

Stock News
·
Jun 10

HBM Holdings Partner Doses First Patient in SKB378 COPD Study

MT Newswires Live
·
Jun 10

HBM Holdings Secures NMPA IND Acceptance for Bispecific Antibody HBM7004 in Advanced Solid Tumors

Bulletin Express
·
Jun 10